top of page
CapitalTrackr
strong financial performance for fiscal year 2024-25 (FY25)!
Total Revenue from Operations : ₹525,784 million (~₹52,578 crore), reflecting a 9% growth compared to FY24. Gross Sales : ₹520,412...
nvshah0610
Jul 291 min read
Why did Sun Pharma’s US formulation sales decline in Q4 FY25!
Sun Pharma’s US formulation sales declined by 2.5% year-over-year to $464 million in Q4 FY25. This decrease was primarily due to...
nvshah0610
Jul 292 min read
How did automating processes and downsizing office space help in boosting profit margins!
Downsizing office space has proven to be an effective measure for boosting profit margins primarily through significant cost savings. By...
nvshah0610
Jul 292 min read
What role did cost control and expense management play in margin growth
Cost control and expense management played a significant role in Sun Pharma’s profit margin growth by enhancing operational efficiency,...
nvshah0610
Jul 292 min read
What factors contributed to Sun Pharma’s increased profit margin in FY25!
Sun Pharma’s increased profit margin in FY25 was driven by several key factors: Shift Toward Specialty Drugs and Better Product Mix : Sun...
nvshah0610
Jul 292 min read
bottom of page